Literature DB >> 743217

The assembly of early components of complement on antibody-antigen aggregates and on antibody-coated erythrocytes.

J W Goers, R R Porter.   

Abstract

Radioimmune assays were developed to assay the binding of complement components C1q, C1s and C4 to antibody aggregates and to cell-bound antibody. The binding of the components was compared with the haemolytic activity and with the capacity to form the C3 convertase activity in the presence of excess C2. The destruction of whole complement and of C4 activity is similar per 1,000 molecules of antibody in aggregates and cell-bound antibody, as is the binding of C1g and C1s, the latter being in a 1:2 molar ratio. The binding of C4 is about 12 times greater, per 1,000 molecules of antibody, on cells than in aggregates. However, the effective C4 molecules, as judged by the formation of C3 convertase activity, are much more similar on cells and aggregates. An assembly mechanism of the early components of complement on antibody-coated cells, which is compatible with these results, is suggested.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 743217      PMCID: PMC1186118          DOI: 10.1042/bj1750675

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

1.  Concerning the mechanism of complement action. I. Inhibition of complement activity by diisopropyl fluophosphate.

Authors:  E L BECKER
Journal:  J Immunol       Date:  1956-12       Impact factor: 5.422

2.  The isolation and structure of C4, the fourth component of human complement.

Authors:  I Gigli; I von Zabern; R R Porter
Journal:  Biochem J       Date:  1977-09-01       Impact factor: 3.857

Review 3.  The eleventh Hopkins Memorial Lecture: The biochemistry of complement.

Authors:  R R Porter
Journal:  Biochem Soc Trans       Date:  1977       Impact factor: 5.407

4.  The purification and properties of the second component of human complement.

Authors:  M A Kerr; R R Porter
Journal:  Biochem J       Date:  1978-04-01       Impact factor: 3.857

5.  Antigens on mouse and rat lymphocytes recognized by rabbit antiserum against rat brain: the quantitative analysis of a xenogeneic antiserum.

Authors:  R J Morris; A F Williams
Journal:  Eur J Immunol       Date:  1975-04       Impact factor: 5.532

6.  Cleavage of C2 by C1s into the antigenically distinct fragments C2a and C2b: demonstration of binding of C2b to C4b.

Authors:  S Nagasawa; R M Stroud
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

7.  Third component of human complement: purification from plasma and physicochemical characterization.

Authors:  B D Tack; J W Prahl
Journal:  Biochemistry       Date:  1976-10-05       Impact factor: 3.162

8.  ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.

Authors:  U R NILSSON; H J MUELLER-EBERHARD
Journal:  J Exp Med       Date:  1965-08-01       Impact factor: 14.307

9.  C'1 ESTERASE EFFECT ON ACTIVITY AND PHYSICOCHEMICAL PROPERTIES OF THE FOURTH COMPONENT OF COMPLEMENT.

Authors:  H J MUELLER-EBERHARD; I H LEPOW
Journal:  J Exp Med       Date:  1965-05-01       Impact factor: 14.307

10.  ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT.

Authors:  H J MUELLER-EBERHARD; C E BIRO
Journal:  J Exp Med       Date:  1963-09-01       Impact factor: 14.307

View more
  13 in total

1.  C3 binds covalently to the C gamma 3 domain of IgG immune aggregates during complement activation by the alternative pathway.

Authors:  L C Antón; J M Alcolea; P Sánchez-Corral; G Marqués; A Sánchez; F Vivanco
Journal:  Biochem J       Date:  1989-02-01       Impact factor: 3.857

2.  The role of complement in the stimulation of lysosomal enzyme release by polymorphonuclear leucocytes induced by immune complexes of IgG and of IgM.

Authors:  Y M Lucisano; B Mantovani
Journal:  Immunology       Date:  1988-10       Impact factor: 7.397

Review 3.  The beta-Cys-gamma-Glu thiolester bond in human C3, C4, and alpha 2-macroglobulin.

Authors:  B F Tack
Journal:  Springer Semin Immunopathol       Date:  1983

4.  Immune complex alterations occur on the human red blood cell membrane.

Authors:  M E Medof; G M Prince
Journal:  Immunology       Date:  1983-09       Impact factor: 7.397

5.  The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.

Authors:  K J Gadd; K B Reid
Journal:  Biochem J       Date:  1981-05-01       Impact factor: 3.857

6.  The binding of human complement component C4 to antibody-antigen aggregates.

Authors:  R D Campbell; A W Dodds; R R Porter
Journal:  Biochem J       Date:  1980-07-01       Impact factor: 3.857

7.  Human complement component C4. Structural studies on the fragments derived from C4b by cleavage with C3b inactivator.

Authors:  E M Press; J Gagnon
Journal:  Biochem J       Date:  1981-11-01       Impact factor: 3.857

8.  Clonal variations in complement activation and deposition of C3b and C4b on model immune complexes.

Authors:  I Yokoyama; F Waxman
Journal:  Immunology       Date:  1993-10       Impact factor: 7.397

9.  Autolytic fragmentation of complement components C3 and C4 under denaturing conditions, a property shared with alpha 2-macroglobulin.

Authors:  R B Sim; E Sim
Journal:  Biochem J       Date:  1981-01-01       Impact factor: 3.857

10.  Limited proteolysis of complement components C2 and factor B. Structural analogy and limited sequence homology.

Authors:  M A Kerr
Journal:  Biochem J       Date:  1979-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.